MENU
+Compare
VTRS
Stock ticker: NASDAQ
AS OF
Sep 17, 04:59 PM (EDT)
Price
$9.62
Change
+$0.06 (+0.63%)
Capitalization
11.19B

VTRS Viatris Forecast, Technical & Fundamental Analysis

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VTRS with price predictions
Sep 16, 2025

VTRS's RSI Indicator sits in oversold zone for 1 day

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for VTRS moved above the 200-day moving average on September 16, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTRS advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

VTRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 200 cases where VTRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VTRS as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VTRS turned negative on August 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

VTRS moved below its 50-day moving average on September 15, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTRS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.716) is normal, around the industry mean (17.157). P/E Ratio (236.200) is within average values for comparable stocks, (74.281). Projected Growth (PEG Ratio) (0.145) is also within normal values, averaging (1.889). VTRS has a moderately high Dividend Yield (0.050) as compared to the industry average of (0.030). P/S Ratio (0.805) is also within normal values, averaging (46.266).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VTRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VTRS is expected to report earnings to 61 cents per share on November 10

Viatris VTRS Stock Earnings Reports
Q3'25
Est.
$0.62
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.07
The last earnings report on August 07 showed earnings per share of 62 cents, beating the estimate of 55 cents. With 6.01M shares outstanding, the current market capitalization sits at 11.19B.
A.I.Advisor
published Dividends

VTRS paid dividends on September 15, 2025

Viatris VTRS Stock Dividends
А dividend of $0.12 per share was paid with a record date of September 15, 2025, and an ex-dividend date of August 22, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
1000 Mylan Boulevard
Phone
+1 724 514-1800
Employees
38000
Web
https://www.viatris.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HYZD22.580.02
+0.09%
WisdomTree Interest Rt Hdg Hi Yld Bd ETF
KAUG25.81-0.02
-0.06%
Innovator U.S. Small Cp Pwr Buf ETF -Aug
SAY25.36-0.04
-0.16%
Saratoga Investment Corp
CCSO24.18-0.14
-0.56%
Carbon Collective Climate Sol US Eq ETF
JQC5.39-0.04
-0.74%
Nuveen Credit Strategies Income Fund

VTRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-0.42%
ELAN - VTRS
53%
Loosely correlated
-0.05%
ZTS - VTRS
47%
Loosely correlated
+0.83%
AMRX - VTRS
43%
Loosely correlated
-0.51%
EBS - VTRS
40%
Loosely correlated
-2.13%
COLL - VTRS
37%
Loosely correlated
+2.00%
More

Groups containing VTRS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-0.42%
Pharmaceuticals: Generic
industry (221 stocks)
14%
Poorly correlated
+0.09%